Corteva Price Target Increases to $72 Following Analyst Updates

Corteva, Inc. (NYSE: CTVA) has seen its price target raised from $70.00 to $72.00 by BNP Paribas Exane, according to a report published on November 4, 2023. This revision reflects a neutral rating on the stock, indicating analysts’ cautious optimism regarding the company’s performance moving forward.

In addition to BNP Paribas, several other financial institutions have provided insights into Corteva’s stock. On November 13, Weiss Ratings reaffirmed a “hold (c)” rating on Corteva shares. Earlier, on September 15, Morgan Stanley set a higher price target of $84.00. Conversely, Jefferies Financial Group adjusted its previous target down from $92.00 to $85.00 on October 2. JPMorgan Chase & Co. upgraded Corteva from a “neutral” to an “overweight” rating, establishing a target price of $67.00 on the same date. Citigroup also increased its target from $67.00 to $68.00, maintaining a neutral stance on the stock.

Analysts are generally optimistic about Corteva, with 15 investment analysts rating the stock as a Buy and 7 others issuing Hold ratings. MarketBeat.com reports that Corteva has an average rating of “Moderate Buy” and a consensus price target of $78.05.

Stock Performance and Financial Metrics

Corteva’s stock opened at $64.63 on November 4, 2023. The company has demonstrated strong financial health, evidenced by a quick ratio of 1.07, a current ratio of 1.58, and a low debt-to-equity ratio of 0.07. The 50-day moving average for Corteva stands at $65.22, while its 200-day moving average is $69.64. The company’s stock has fluctuated significantly over the past year, with a fifty-two week low of $53.40 and a high of $77.41. Currently, Corteva holds a market capitalization of $43.67 billion and a price-to-earnings ratio of 27.62.

The company recently reported its earnings from the previous quarter, revealing an earnings per share (EPS) of ($0.23), which surpassed analyst expectations of ($0.49) by $0.26. Corteva generated revenues of $2.62 billion during this period, exceeding the forecasted $2.47 billion. This marks a 6.5% increase in revenue compared to the same quarter last year, when the EPS was reported at ($0.49). Analysts project Corteva will post an EPS of 2.96 for the current financial year.

Dividends and Shareholder Updates

Corteva has also announced a quarterly dividend of $0.18 per share, scheduled for payment on December 15, 2023. Shareholders of record by December 1, 2023 will be eligible for this dividend, which translates to an annualized yield of 1.1%. The company’s dividend payout ratio is currently at 30.77%.

In corporate governance news, Executive Vice President Robert D. King sold 37,280 shares of Corteva stock on August 29, 2023, at an average price of $74.20, totaling approximately $2.77 million. Following this transaction, King holds 49,262 shares valued at about $3.66 million, reflecting a 43.08% decrease in his position. Insider ownership stands at 0.14% of the company’s stock.

Institutional investors remain heavily invested in Corteva, owning approximately 81.54% of the company’s shares. Recent reports indicate that Vanguard Group Inc. increased its holdings by 0.5% in the second quarter, now owning over 80 million shares. State Street Corp raised its position by 3.6%, acquiring more than 1.2 million shares in the third quarter. Franklin Resources Inc. and Geode Capital Management LLC also boosted their stakes, reflecting strong institutional confidence in Corteva’s growth potential.

Corteva, Inc. operates primarily in the agriculture sector, focusing on seed development and crop protection solutions. The company aims to enhance agricultural productivity through advanced germplasm and trait technologies, catering to the evolving needs of farmers globally.